Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$980K Buy
20,337
+8,847
+77% +$412K 0.01% 940
2025
Q4
$557K Buy
11,490
+6,306
+122% +$313K ﹤0.01% 1103
2025
Q3
$245K Buy
5,184
+277
+6% +$13.4K ﹤0.01% 1371
2025
Q2
$237K Sell
4,907
-2,003
-29% -$102K ﹤0.01% 1299
2025
Q1
$383K Buy
6,910
+8
+0.1% +$433 ﹤0.01% 1129
2024
Q4
$333K Sell
6,902
-3,921
-36% -$199K ﹤0.01% 1170
2024
Q3
$624K Sell
10,823
-327
-3% -$17.7K 0.01% 930
2024
Q2
$540K Buy
11,150
+3,597
+48% +$174K ﹤0.01% 945
2024
Q1
$367K Sell
7,553
-392
-5% -$19.1K ﹤0.01% 1101
2023
Q4
$395K Sell
7,945
-440
-5% -$21.5K ﹤0.01% 1031
2023
Q3
$450K Sell
8,385
-5,462
-39% -$291K ﹤0.01% 948
2023
Q2
$746K Sell
13,847
-955
-6% -$51.4K 0.01% 788
2023
Q1
$806K Sell
14,802
-1,626
-10% -$79.1K 0.01% 750
2022
Q4
$796K Buy
16,428
+6,424
+64% +$282K 0.01% 699
2022
Q3
$380K Buy
10,004
+4,161
+71% +$185K 0.01% 912
2022
Q2
$292K Buy
5,843
+625
+12% +$33.2K ﹤0.01% 1025
2022
Q1
$268K Buy
5,218
+100
+2% +$5.16K ﹤0.01% 1116
2021
Q4
$256K Sell
5,118
-150
-3% -$7.42K ﹤0.01% 1102
2021
Q3
$254K Buy
5,268
+150
+3% +$7.63K ﹤0.01% 1079
2021
Q2
$270K Sell
5,118
-110
-2% -$5.74K ﹤0.01% 1033
2021
Q1
$259K Sell
5,228
-200
-4% -$9.61K ﹤0.01% 1005
2020
Q4
$264K Sell
5,428
-300
-5% -$14.8K ﹤0.01% 889
2020
Q3
$287K Buy
5,728
+241
+4% +$12.4K 0.01% 784
2020
Q2
$280K Buy
5,487
+391
+8% +$19K 0.01% 766
2020
Q1
$223K Sell
5,096
-351
-6% -$16.8K ﹤0.01% 840
2019
Q4
$273K Buy
5,447
+579
+12% +$27.1K ﹤0.01% 861
2019
Q3
$226K Buy
+4,868
New +$210K ﹤0.01% 885
2018
Q4
Sell
-4,553
Closed -$203K 1159
2018
Q3
$203K Sell
4,553
-2,249
-33% -$96.1K ﹤0.01% 1072
2018
Q2
$272K Buy
6,802
+231
+4% +$9.09K 0.01% 914
2018
Q1
$263K Buy
6,571
+606
+10% +$25.2K 0.01% 894
2017
Q4
$257K Buy
5,965
+1,017
+21% +$46.9K 0.01% 910
2017
Q3
$246K Sell
4,948
-411
-8% -$19.9K ﹤0.01% 927
2017
Q2
$256K Sell
5,359
-1,102
-17% -$52.7K 0.01% 855
2017
Q1
$292K Sell
6,461
-87
-1% -$3.69K 0.01% 793
2016
Q4
$263K Sell
6,548
-171
-3% -$6.74K 0.01% 883
2016
Q3
$254K Buy
6,719
+1,231
+22% +$49.4K 0.01% 849
2016
Q2
$227K Buy
5,488
+562
+11% +$23K 0.01% 802
2016
Q1
$196K Sell
4,926
-736
-13% -$29.6K 0.01% 844
2015
Q4
$239K Sell
5,662
-872
-13% -$40.1K 0.01% 784
2015
Q3
$309K Sell
6,534
-603
-8% -$30.7K 0.01% 671
2015
Q2
$351K Sell
7,137
-1,053
-13% -$53.4K 0.01% 673
2015
Q1
$403K Buy
8,190
+592
+8% +$28.3K 0.01% 633
2014
Q4
$344K Sell
7,598
-7,807
-51% -$379K 0.01% 688
2014
Q3
$867K Buy
15,405
+328
+2% +$17.6K 0.03% 448
2014
Q2
$799K Sell
15,077
-699
-4% -$37.1K 0.03% 477
2014
Q1
$822K Buy
15,776
+2,082
+15% +$105K 0.03% 465
2013
Q4
$731K Buy
13,694
+9,614
+236% +$496K 0.03% 483
2013
Q3
$204K Sell
4,080
-5
-0.1% -$254 0.01% 694
2013
Q2
$208K Buy
+4,085
New +$218K 0.01% 662

Other funds holding SNY

D.A. Davidson & Co's SNY Position: Q1 2026 in Review

D.A. Davidson & Co increased its Sanofi (SNY) stake by 77% in Q1 2026, buying an estimated $412K and bringing the position to 20,337 shares worth $980K. The position accounts for 0.01% of the portfolio, ranked #940.

D.A. Davidson & Co first reported a position in SNY in Q2 2013 and has held it in 49 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • D.A. Davidson & Co held 20,337 shares of Sanofi worth $980K as of Q1 2026.
  • D.A. Davidson & Co bought 8,847 Sanofi shares in Q1 2026, an estimated $412K.
  • Sanofi made up 0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #940 holding.
  • D.A. Davidson & Co first reported a position in Sanofi in Q2 2013 and has held it in 49 quarters since.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.